Source: Bloomberg Law

Quincy Bioscience: Prevagen Maker Must Stop Using Memory Aid Marketing Statements

Prevagen maker Quincy Bioscience Holding Co. Inc. and its co-founder must immediately stop using eight marketing claims that promote the jellyfish-based memory aid wherever it's marketed nationwide, a federal judge said.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Michael Beaman's photo - Chairman & CEO of Quincy Bioscience

Chairman & CEO

Michael Beaman

CEO Approval Rating

83/100

Read more